Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Hoshang Yousefi"'
Autor:
Mehrdad Payandeh, Mohammad Erfan Zare, Atefeh Nasir Kansestani, Shirin Falah Pakdel, Firuzeh Jahanpour, Hoshang Yousefi, Farzaneh Soleimanian
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 7, Iss 2, Pp 11-16 (2013)
Background: Transfusion services rely on transfusion reaction reporting to provide patient care and protect the blood supply. Unnecessary discontinuation of blood is a major wastage of scarce blood, as well as man, hours and funds. The aim of the pre
Externí odkaz:
https://doaj.org/article/74583a56819b4a9488b14a525272bc6e
Autor:
Mehrnoush Aeinfar, Farhad Shaveisi Zadeh, Mahmood Aeinfar, Amir Hossein Hashemian, Dariush Pourmand, Zohreh Rahimi, Atefeh Nasir Kansestani, Mohammad Erfan Zare, Hoshang Yousefi, Mehrdad Payandeh
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 6, Iss 2, Pp 17-21 (2012)
Introduction: The main inhibitors of coagulation pathway are antithrombin (AT), protein C and protein S. These inhibitors are necessary to prevent thromboembolism. Hereditary deficiency of inhibitors is the main cause of alteration in balance between
Externí odkaz:
https://doaj.org/article/5c3cfea11d5648fdbf9fea5bf001ea3a
Autor:
Hoshang Yousefi, Saeed Alimoradi, Reza Khodarahmi, Kamran Mansouri, Mohammad Erfan Zare, Farhad Shaveisi Zadeh, Mehrdad Payandeh, Fatemeh Darabi
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 5, Iss 3, Pp 16-20 (2011)
Introduction: The myeloproliferative neoplasms (MPNs) are a heterogeneous group of diseases characterized by excessive production of blood cells by hematopoietic precursors. Typically, they include polycythemia vera (PV), essential thrombocythemia (E
Externí odkaz:
https://doaj.org/article/b7ac6bd4d29b40718322cf819013c57a
Autor:
Hoshang Yousefi, Ebrahim Soltanian, Amir Hossein Hashemian, Zohreh Rahimi, Kamran Mansouri, Mohammad Erfan Zare, Mehrdad Payandeh
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 5, Iss 2, Pp 5-8 (2011)
Introduction: Normal homeostasis system has several inhibitor mechanisms in front of the amplifiers natural clotting enzyme to prevent fibrin clots in the vessels. The main inhibitors of coagulation pathway are antithrombin (AT), protein C and protei
Externí odkaz:
https://doaj.org/article/a1df3b2efa3c4742bbc5aba6a7bc8632
Autor:
Mehrdad Payandeh, Hoshang Yousefi, Mohammad Erfan Zare, Atefeh Nasir Kansestani, Zohreh Rahimi, Dariush Pourmand, Amir Hossein Hashemian, Mahmood Aeinfar, Mehrnoush Aeinfar, Farhad Shaveisi Zadeh
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 6, Iss 2 (2012)
Introduction: The main inhibitors of coagulation pathway are antithrombin (AT), protein C and protein S. These inhibitors are necessary to prevent thromboembolism. Hereditary deficiency of inhibitors is the main cause of alteration in balance between
Externí odkaz:
https://doaj.org/article/cfc2f6343f804406b3418d6c25029654
Autor:
Mehrdad Payandeh, Farhad Shaveisi Zadeh, Mohammad Erfan Zare, Kamran Mansouri, Reza Khodarahmi, Saeed Alimoradi, Hoshang Yousefi, Fatemeh Darabi
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 5, Iss 3 (2011)
Introduction: The myeloproliferative neoplasms (MPNs) are a heterogeneous group of diseases characterized by excessive production of blood cells by hematopoietic precursors. Typically, they include polycythemia vera (PV), essential thrombocythemia (E
Externí odkaz:
https://doaj.org/article/1e0f7e8d4c524e15a6de5c7012367486
Autor:
Mehrdad Payandeh, Mohammad Erfan Zare, Atefeh Nasir Kansestani, Kamran Mansouri, Zohreh Rahimi, Amir Hossein Hashemian, Ebrahim Soltanian, Hoshang Yousefi
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 5, Iss 2 (2011)
Introduction: Normal homeostasis system has several inhibitor mechanisms in front of the amplifier’s natural clotting enzyme to prevent fibrin clots in the vessels. The main inhibitors of coagulation pathway are antithrombin (AT), protein C and pro
Externí odkaz:
https://doaj.org/article/44a1293cef0247d5a4dc2e0fdad64de0